Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Should Value Investors Buy Bank OZK (OZK) Stock?Photo, wide shot, wide-angle lens,  Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png
Should Value Investors Buy Bank OZK (OZK) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Is Beam Therapeutics (BEAM) Stock Outpacing Its Medical Peers This Year?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Is Beam Therapeutics (BEAM) Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Beam Therapeutics Inc. (BEAM) is a stock that can certainly

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Are Consumer Discretionary Stocks Lagging  AMark Precious Metals (AMRK) This Year?Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Are Consumer Discretionary Stocks Lagging AMark Precious Metals (AMRK) This Year?

The Consumer Discretionary group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has A-Mark Precious Metals (AMRK) been one of

Are Investors Undervaluing Scor (SCRYY) Right Now?
Are Investors Undervaluing Scor (SCRYY) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Here's Why CRA International (CRAI) is a Strong Value Stock
Here's Why CRA International (CRAI) is a Strong Value Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Should Value Investors Buy Ameriprise Financial (AMP) Stock?
Should Value Investors Buy Ameriprise Financial (AMP) Stock?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Is Coca-Cola HBC (CCHGY) Stock Outpacing Its Consumer Staples Peers This Year?
Is Coca-Cola HBC (CCHGY) Stock Outpacing Its Consumer Staples Peers This Year?

For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. Coca-Cola HBC (CCHGY) is a stock that can certainly

Should Value Investors Buy AAC Technologies (AACAY) Stock?
Should Value Investors Buy AAC Technologies (AACAY) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Should Value Investors Buy Private Bancorp of America (PBAM) Stock?
Should Value Investors Buy Private Bancorp of America (PBAM) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Why Array Technologies, Inc. (ARRY) is a Top Value Stock for the Long-Term
Why Array Technologies, Inc. (ARRY) is a Top Value Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

VLO Poised to Report Q3 Earnings: Here's What You Need to Know
VLO Poised to Report Q3 Earnings: Here's What You Need to Know

Valero Energy Corporation VLO is set to report third-quarter 2025 results on Oct. 23, before the opening bell.

In the last reported quarter, its adjusted earnings of $2.28 per share beat the Zacks

MGM Resorts to Sell MGM Northfield Park Operations for $546MPhoto, wide shot, wide-angle lens,  Hedge fund, neutral atmosphere, photo by Charlie Waite: https://img.theapi.app/temp/95282efd-f725-49c0-be40-aa74627f7ccc.png
MGM Resorts to Sell MGM Northfield Park Operations for $546M

MGM Resorts International MGM has announced an agreement to divest the operations of MGM Northfield Park to private equity funds managed by Clairvest Group Inc. in a deal valued at $546 million in

After Plunging 18.6% in 4 Weeks, Here's Why the Trend Might Reverse for Marcus (MCS)
After Plunging 18.6% in 4 Weeks, Here's Why the Trend Might Reverse for Marcus (MCS)

Marcus (MCS) has been beaten down lately with too much selling pressure. While the stock has lost 18.6% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

Genpact (G) Loses 5.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Genpact (G) Loses 5.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Genpact (G) has been on a downward spiral lately with significant selling pressure. After declining 5.7% over the past four weeks, the stock looks well positioned for a trend reversal as it is now

Down 6% in 4 Weeks, Here's Why You Should You Buy the Dip in Cheniere Energy (LNG)
Down 6% in 4 Weeks, Here's Why You Should You Buy the Dip in Cheniere Energy (LNG)

A downtrend has been apparent in Cheniere Energy (LNG) lately with too much selling pressure. The stock has declined 6.1% over the past four weeks. However, given the fact that it is now in oversold

Down 15.4% in 4 Weeks, Here's Why Amphastar (AMPH) Looks Ripe for a TurnaroundPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Down 15.4% in 4 Weeks, Here's Why Amphastar (AMPH) Looks Ripe for a Turnaround

A downtrend has been apparent in Amphastar Pharmaceuticals (AMPH) lately with too much selling pressure. The stock has declined 15.4% over the past four weeks. However, given the fact that it is now

After Plunging 14.2% in 4 Weeks, Here's Why the Trend Might Reverse for First Horizon (FHN)
After Plunging 14.2% in 4 Weeks, Here's Why the Trend Might Reverse for First Horizon (FHN)

First Horizon National (FHN) has been on a downward spiral lately with significant selling pressure. After declining 14.2% over the past four weeks, the stock looks well positioned for a trend

Teledyne Technologies to Report Q3 Earnings: Here's What to Expect
Teledyne Technologies to Report Q3 Earnings: Here's What to Expect

Teledyne Technologies TDY is scheduled to release third-quarter 2025 results on Oct. 22, before market open. The company delivered an earnings surprise of 3.6% in the last reported quarter. Let’s

Will Nebius' Toloka and ClickHouse Stakes Fund Its AI Expansion?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a130cb51-4ded-41be-b600-b83e2078ad65.png
Will Nebius' Toloka and ClickHouse Stakes Fund Its AI Expansion?

Nebius Group N.V. NBIS is an Amsterdam-based AI infrastructure neo cloud company. NBIS is witnessing hyper revenue growth (up 625% last quarter) as demand for AI infrastructure has exploded, fueled

Compared to Estimates, Infosys (INFY) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Infosys (INFY) Q2 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Infosys (INFY) reported revenue of $5.08 billion, up 3.7% over the same period last year. EPS came in at $0.20, compared to $0.19 in the year-ago quarter.

The

State Street (STT) Reports Q3 Earnings: What Key Metrics Have to Say
State Street (STT) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, State Street Corporation (STT) reported revenue of $3.55 billion, up 6.2% over the same period last year. EPS came in at $2.78, compared to $2.26 in the